Aquarius Surgical Technologies Inc.
AQQRF
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -58.36% | -53.63% | -56.73% | -47.59% | -20.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -58.36% | -53.63% | -56.73% | -47.59% | -20.45% |
| Cost of Revenue | -59.47% | -38.60% | -40.86% | -33.28% | -15.53% |
| Gross Profit | -57.36% | -61.66% | -65.35% | -56.41% | -24.42% |
| SG&A Expenses | -21.33% | -19.16% | -7.45% | 1.96% | -18.02% |
| Depreciation & Amortization | -12.89% | -12.61% | -8.30% | 4.27% | 40.63% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -25.07% | -20.58% | -10.96% | -1.85% | -16.15% |
| Operating Income | 15.26% | 9.44% | -8.20% | -16.92% | 14.77% |
| Income Before Tax | 6.53% | 73.18% | -49.87% | -38.11% | -16.69% |
| Income Tax Expenses | 7.69% | -78.85% | -83.58% | 246.67% | 246.67% |
| Earnings from Continuing Operations | 6.41% | 73.23% | -48.31% | -38.80% | -17.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.41% | 73.23% | -48.31% | -38.80% | -17.36% |
| EBIT | 15.26% | 9.44% | -8.20% | -16.92% | 14.77% |
| EBITDA | 15.29% | 9.29% | -8.85% | -17.68% | 16.17% |
| EPS Basic | 6.19% | 72.64% | -49.26% | -39.53% | -12.44% |
| Normalized Basic EPS | 5.71% | -1.50% | -11.90% | -21.43% | 2.78% |
| EPS Diluted | 6.19% | 72.64% | -49.26% | -39.53% | -12.44% |
| Normalized Diluted EPS | 5.71% | -1.50% | -11.90% | -21.43% | 2.78% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.05% | 2.95% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.05% | 2.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |